PTK2 and small cell lung carcinoma: We tested the effects of FAK inhibitors on SCLC cells and found that PF56227158 at 0.25 to 1.5 μM had much lower inhibitory effects on FAK-expressing lines than on FAK6,7-harboring lines (Supplementary Fig. 12b).